ArticleOxford medical case reports2026
Rhabdomyolysis after ERCP in a patient with pancreatic adenocarcinoma: a paraneoplastic phenomenon?
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParaneoplastic myopathies are rare complications of malignancy, most often associated with lung, ovarian, and gastrointestinal cancers. Rhabdomyolysis as a paraneoplastic manifestation of pancreatic adenocarcinoma is exceedingly uncommon and typically portends a poor prognosis. CASE PRESENTATION: We describe an 80-year-old male with newly diagnosed pancreatic adenocarcinoma who developed fulminant rhabdomyolysis shortly after endoscopic ultrasound and ERCP with biliary stent placement. Laboratory studies showed CPK levels > 66 000 U/l and serum myoglobin > 40 000 ng/ml, leading to acute kidney injury and multiorgan failure despite aggressive fluid resuscitation, corticosteroids, CRRT, and broad-spectrum antibiotics. Autoimmune and paraneoplastic serologies were unrevealing. The patient died on hospital day five.
conclusionThe rapid onset of rhabdomyolysis following ERCP raises the possibility that tumor manipulation or antigenic exposure may serve as an immune trigger for paraneoplastic muscle injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.